Derivation and validation of a clinical predictive model of NT-proBNP ≥125 pg/mL to detect pre-heart failure

Heidenreich, 2022, 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines, J Am Coll Cardiol, 79, e263, 10.1016/j.jacc.2021.12.012 McDonagh, 2021, 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, Eur Heart J, 42, 3599, 10.1093/eurheartj/ehab368 Tsutsui, 2019, JCS 2017/JHFS 2017 Guideline on diagnosis and treatment of acute and chronic heart failure- digest version, Circ J, 83, 2084, 10.1253/circj.CJ-19-0342 Collins, 2015, Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. The TRIPOD Group, Circulation, 131, 211, 10.1161/CIRCULATIONAHA.114.014508 Sasaki, 2018, Association of N-terminal pro B-type natriuretic peptide with blood pressure and pulse pressure in elderly people- a cross-sectional population study, Circ J, 82, 2049, 10.1253/circj.CJ-18-0031 Raymond, 2003, The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population, Heart, 89, 745, 10.1136/heart.89.7.745 Matsuzawa, 1990, Simple estimation of ideal body weight from body mass index with the lowest morbidity, Diabetes Res Clin Pract, 10, S159, 10.1016/0168-8227(90)90157-O Forman, 1992, PTCA in the elderly: the “young-old” versus the “old-old”, J Am Geriatr Soc, 40, 19, 10.1111/j.1532-5415.1992.tb01823.x Unger, 2020, 2020 International Society of Hypertension global hypertension practice guidelines, Hypertension, 75, 1334, 10.1161/HYPERTENSIONAHA.120.15026 Stevens, 2013, Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline, Ann Intern Med, 158, 825, 10.7326/0003-4819-158-11-201306040-00007 1968, World Health Organ Tech Rep Ser, 405, 5 Teramoto, 2013, Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 version, J Atheroscler Thromb, 20, 517, 10.5551/jat.15792 Teramoto, 2013, Diagnostic criteria for dyslipidemia, J Atheroscler Thromb, 20, 655, 10.5551/jat.17152 Shichiri, 2000, Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients, Diabetes Care, 23, B21 Stratton, 2000, Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study, BMJ, 321, 405, 10.1136/bmj.321.7258.405 Gleeson, 2010, The chest radiograph in heart disease, Medicine, 38, 357, 10.1016/j.mpmed.2010.03.012 Salah, 2014, A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score, Heart, 100, 115, 10.1136/heartjnl-2013-303632 Sasaki, 2013, Development and validation of an acute heart failure-specific mortality predictive model based on administrative data, Can J Cardiol, 29, 1055, 10.1016/j.cjca.2012.11.021 Anker, 2021, Empagliflozin in heart failure with a preserved ejection fraction, N Engl J Med, 385, 1451, 10.1056/NEJMoa2107038 Ledwidge, 2013, Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial, JAMA, 310, 66, 10.1001/jama.2013.7588 Huelsmann, 2013, PONTIAC (NT-proBNP selected prevention of cardiac events in a population of diabetic patients without a history of cardiac disease): a prospective randomized controlled trial, J Am Coll Cardiol, 62, 1365, 10.1016/j.jacc.2013.05.069 Anwaruddin, 2006, Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study, J Am Coll Cardiol, 47, 91, 10.1016/j.jacc.2005.08.051 Das, 2005, Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study, Circulation, 112, 2163, 10.1161/CIRCULATIONAHA.105.555573 Madamanchi, 2014, Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure, Int J Cardiol, 176, 611, 10.1016/j.ijcard.2014.08.007 Carbone, 2020, The impact of obesity in heart failure, Heart Fail Clin, 16, 71, 10.1016/j.hfc.2019.08.008 Seko, 2020, Association between body mass index and prognosis of patients hospitalized with heart failure, Sci Rep, 10, 16663, 10.1038/s41598-020-73640-w Jittham, 2019, Correlation between heart failure with N-terminal-pro-B type natriuretic peptide and cardiothoracic ratio from chest radiograph in pediatric heart disease, Siriraj Med J, 71, 356, 10.33192/Smj.2019.54 Maisel, 2008, State of the art: using natriuretic peptide levels in clinical practice, Eur J Heart Fail, 10, 824, 10.1016/j.ejheart.2008.07.014